IHS Chemical Week
CHEM IDEAS

Chemical industry weekly news roundup, 12 December

December 12, 2014 | By LINDSAY FROST

This Week in CW: US chemical output is set accelerate sharply through the end of the decade, exceeding the growth of the overall US economy, according to ACC’s Year End 2014 Chemical Industry Situation and Outlook, published this week. ACC forecasts a 3.7% US chemical output gain in 2015, up from 2% in 2014, and an even stronger gain of 3.9% for 2016. The forecast puts the US chemical industry on...

Pharma/fine chemicals roundup—9 December 2014

December 9, 2014 | By DEEPTI RAMESH

Johnson Matthey acquires pharmaceutical ingredients facility in UK Johnson Matthey says that it has completed the acquisition of a pharmaceutical manufacturing facility at Annan, UK. The site, which was originally constructed by Glaxo in 1980, changed hands several times and was most recently owned by Bakhu Pharma (Bromborough, UK). A multimillion-pound refurbishment will start in early 2015 to update and...

Chemical industry weekly news roundup, 5 December

December 5, 2014 | By LINDSAY FROST

This Week in CW: Vertellus (Indianapolis), a leading producer of specialty chemicals for the life sciences sector and other industrial applications, has signed a definitive agreement to acquire the sodium borohydride business, including associated assets, from the Dow Chemical, Vertellus announced today. The company is a portfolio company of private equity firm Wind Point Partners (Chicago). Wind Point...

Pharma/fine chemicals roundup—2 December 2014

December 2, 2014 | By DEEPTI RAMESH

Siegfried acquires German pharma firm Siegfried (Zofingen, Switzerland), a producer of active pharmaceutical ingredients (APIs), pharma intermediates, and finished drugs, says that it has acquired Hameln Pharma (Hameln, Germany) from the privately held Hameln Group, for 60 million Swiss francs ($62 million). Hameln Pharma is active in the development and production of sterile liquid pharmaceutical...

Pharma/fine chemicals roundup—25 November 2014

November 25, 2014 | By DEEPTI RAMESH

AbbVie acquires API facility in Singapore AbbVie (Chicago) say that it has acquired a small molecule active pharmaceutical ingredient (API) manufacturing site in Singapore's Tuas Biomedical Park. The Singapore site, AbbVie's first manufacturing facility in Asia, is about 120,000 square meters and includes a contained API facility, additional buildings and ancillary equipment. The API facility is expected...

Pharma/fine chemicals roundup—18 November 2014

November 18, 2014 | By DEEPTI RAMESH

FDA issues warning letter to Cadila's API plant in India The US FDA issued a warning letter on 15 October to the active pharmaceutical ingredient (API) manufacturing facility of Cadila Pharmaceuticals (Ahmedabad, India), which is located at Ankleshwar, India, for deviations from cGMP. An FDA inspection from 24–28 March at the facility identified significant deviations from cGMP for the manufacture of...

Chemical industry weekly news roundup, 14 November

November 14, 2014 | By LINDSAY FROST

This Week in CW: Dow Chemical held its investor day this week and made several announcements. The company says it plans to cut its stake in its Kuwaiti petrochemical joint ventures and sell its Angus Chemical subsidiary to private equity firm Golden Gate Partners for $1.2 billion. The company also announced plans to realign external reporting, increase its dividend, and expand a shareholder repurchase...

Pharma/fine chemicals roundup—11 November 2014

November 11, 2014 | By DEEPTI RAMESH

API business of Dr. Reddy’s reports a slight fall in sales The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 0.2% fall in sales in the company’s fiscal second quarter, ended 30 September, compared with the year-ago quarter, to 6.39 billion Indian rupees ($104 million). Earnings figures for the PSAI business have not...

Pharma/fine chemicals roundup—4 November 2014

November 4, 2014 | By DEEPTI RAMESH

New York-based private equity firm buys minority stake in Indian API manufacturer Laurus for $90 million Private equity firm Warburg Pincus (New York) says that it has acquired a minority stake in Laurus Labs (Hyderabad, India), a leading developer and manufacturer of active pharmaceutical ingredients (APIs), for about 5.5 billion Indian rupees ($90 million). Laurus is a leading manufacturer of APIs for...

Pharma/fine chemicals roundup—28 October 2014

October 28, 2014 | By DEEPTI RAMESH

Feature: API firms eye more investments, acquisitions Pharmaceutical ingredient manufacturers from various parts of the world, interviewed by CW during the CPhI trade fair held in Paris earlier this month, said they are very optimistic about the outlook for the industry and outlined investment plans to grow their businesses further. Several manufacturers of active pharmaceutical ingredients (APIs) told CW...


ABOUT CHEM IDEAS

Welcome to Chem Ideas, the place for opinions and perspective on the key issues affecting the global chemicals industry. This zone features articles by Chemweek’s regular editors as well as a team of established experts with insights across the chemicals industry. If you would like to contribute a blog or opinion piece contact  Lindsay.Frost@ihs.com.



CLICK HERE TO LEARN ABOUT CHEMWEEK'S EDITORS

ABOUT OUR GUEST AUTHORS

Girish Malhotra

Fine Chemicals / Pharma
Girish Malhotra is the president and founder of Epcot International, an international consulting firm covering chemical manufacture. Girish is an established industry figure having held senior positions at companies including ExxonMobil and Sherwin Williams. He can be reached at girish@epcotint.com


SOCMA
Lawrence D. Sloan became Socma's
President in early 2010. He says he will continue to drive up the interests of his members on issues including regulation and best business practice.

Lisa Allen

REACH
Lisa Allen  is the Technical Manager of ReachReady, the Reach services body affiliated to the Chemical Industries Assocation (CIA; U.K.).
She spends much of her time addressing concerns raised by ReachReady’s customers about Reach. 

Environment

Kathryn Sheridan is the founder of Sustainability Consult, providing public relations support with a sustainability focus to a number of chemical industry clients, as well as to other sectors.  Sustainability Consult helps organisations develop, promote and communicate their sustainability strategies, plans and activities. ks@sustainabilityconsult.com

Rubber and Plastics

Lou Reade is a freelance journalist and expert in the rubber and plastics fields. Based in the U.K. Lou has more than a decade writing in about rubber and plastics manufacture with a wealth of experience gained while writing for the leading publications in the field in the U.K. and wider afield. Loureade@talk21.com.


EU Regulation


Giles Chappell is an attorney based in Geneva. His practice focuses on chemicals—specifically REACH and the CLP Regulation, product safety legislation, environmental and trade compliance, and market access issues. He was recommended in 2012 by the Chambers & Partners legal directory. gchappell@eulegal.org

Steve RobertsSecurity

Steve Roberts is an attorney who practices in the rapidly developing area of homeland security law and regulation. Steve writes and speaks frequently on the legal aspects of homeland security and counterterrorism affecting the nation’s critical infrastructure.  www.chemicalsecurity.com











 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa